Age-Related Macular Degeneration
Brolucizumab, an inhibitor of vascular endothelial growth factor, has been associated with intraocular inflammation and occlusive retinal vasculitis resulting in irreversible vision loss in some patients.
Adverse Ocular Effects of Systemic Drugs
Pentosan polysulfate (used to treat interstitial cystitis) has been associated with progressive vision loss due to maculopathy.
Patients who receive pentosan polysulfate should be monitored with annual eye examinations.